NLRP3 and major depressive disorder: Although no clinical studies have investigated the association between NLRP3 or its methylation changes and brain structural alterations in MDD, several neuroimaging studies have identified that increased peripheral inflammatory markers are associated with brain structural changes in MDD [45,46,47].